![Walter Egger](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profil
Walter Egger worked as a Portfolio Manager at AlpenBank AG from 2007 to 2022.
Ehemalige bekannte Positionen von Walter Egger
Unternehmen | Position | Ende |
---|---|---|
AlpenBank AG
![]() AlpenBank AG Investment ManagersFinance Part of Alpen Privatbank AG, AlpenBank AG is an Austrian company that focuses on chronic heart disease called hypertrophic cardiomyopathy (HCM). Founded in 1983, the company is based in Innsbruck, Austria. HCM is a serious heart condition that affects the heart muscle, causing the walls of the heart to become thicker than they should be. This excessive thickening can cause the heart to become more stiff, leaving less room for blood to fill the heart. As a result, those with HCM may experience fatigue, a fast heartbeat, chest pain, breathing problems, or light-headedness which may interfere with a patient’s ability to participate in activities of daily living. HCM has also been associated with increased risk of atrial fibrillation (irregular heartbeat), stroke, heart failure, and in rare cases, sudden cardiac death. | Mitglied des Investmentausschusses | 11.01.2022 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
AlpenBank AG
![]() AlpenBank AG Investment ManagersFinance Part of Alpen Privatbank AG, AlpenBank AG is an Austrian company that focuses on chronic heart disease called hypertrophic cardiomyopathy (HCM). Founded in 1983, the company is based in Innsbruck, Austria. HCM is a serious heart condition that affects the heart muscle, causing the walls of the heart to become thicker than they should be. This excessive thickening can cause the heart to become more stiff, leaving less room for blood to fill the heart. As a result, those with HCM may experience fatigue, a fast heartbeat, chest pain, breathing problems, or light-headedness which may interfere with a patient’s ability to participate in activities of daily living. HCM has also been associated with increased risk of atrial fibrillation (irregular heartbeat), stroke, heart failure, and in rare cases, sudden cardiac death. | Finance |